Max Papkov joined Centerview Capital in 2011. As a Vice President, he is involved in the due diligence and execution of new investment opportunities as well as the strategic planning and analysis for portfolio companies.
Prior to joining Centerview Capital, Max was an analyst at Centerview Partners, where he worked on a variety of transactions in the Consumer, Healthcare and Technology sectors. Earlier, Max was an analyst in the Mergers and Acquisitions Group at Merrill Lynch.
Max graduated from Rutgers University with a B.S. in Finance. He is a member of the Board of Directors of Richelieu Foods.